GBI Research
Trending Articles
Related Content
Ingredients
Industry pipeline for mAbs reaches an unprecedented scale
The overall industry pipeline for monoclonal antibodies (mAbs) has reached a unprecedented scale now accounting for almost 3000 distinct pipeline programmes across a range of therapy areas, according to business intelligence provider GBI Research
Media
Steep rise in type 2 diabetes in South-East Asia
The latest report “Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 — Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth” from business intelligence provider GBI Research reveals that there has been a steep rise in type 2 Diabetes Mellitus (T2DM) cases across South-East Asian in the past decade
Finance
Asia-Pacific hepatitis C market to surpass $8.3 billion by 2023
The hepatitis C market across the Asia-Pacific (APAC) region, which includes India, China, Australia, South Korea and Japan, is forecast to grow from $5.3 billion in 2016 to $8.3 billion by 2023, at a compound annual growth rate of 6.4%, according to business intelligence provider GBI Research
Media
Painkillers market to hit $28.8 billion by 2023 thanks to new drug approvals
The global pain therapeutics space is forecast to grow from $19.7 billion in 2016 to around $28.8 billion in 2023, representing a compound annual growth rate of 5.5%, according to business intelligence provider GBI Research